Insider Selling: Laboratory Co. of America Holdings (NYSE:LH) EVP Sells $239,420.00 in Stock

Laboratory Co. of America Holdings (NYSE:LH) EVP Der Vaart Sandra D. Van sold 1,000 shares of Laboratory Co. of America stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $239.42, for a total value of $239,420.00. Following the transaction, the executive vice president now owns 2,670 shares of the company’s stock, valued at $639,251.40. The trade was a 27.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Laboratory Co. of America Stock Performance

LH opened at $242.18 on Thursday. The firm has a market cap of $20.26 billion, a P/E ratio of 46.84, a price-to-earnings-growth ratio of 1.99 and a beta of 1.05. The business’s fifty day moving average is $226.97 and its 200-day moving average is $217.78. Laboratory Co. of America Holdings has a 52-week low of $191.97 and a 52-week high of $247.99. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.30 and a current ratio of 1.44.

Laboratory Co. of America (NYSE:LH) last released its earnings results on Thursday, October 24th. The medical research company reported $3.50 EPS for the quarter, beating the consensus estimate of $3.48 by $0.02. Laboratory Co. of America had a net margin of 3.43% and a return on equity of 15.27%. The firm had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.26 billion. During the same period last year, the firm earned $3.38 EPS. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. Sell-side analysts expect that Laboratory Co. of America Holdings will post 14.53 EPS for the current fiscal year.

Laboratory Co. of America Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Tuesday, November 26th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $2.88 annualized dividend and a dividend yield of 1.19%. Laboratory Co. of America’s payout ratio is 55.71%.

Analyst Ratings Changes

Several brokerages have recently commented on LH. Hsbc Global Res upgraded Laboratory Co. of America from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 30th. HSBC raised shares of Laboratory Co. of America from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. Bank of America increased their price objective on shares of Laboratory Co. of America from $240.00 to $260.00 and gave the company a “buy” rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Laboratory Co. of America from $220.00 to $230.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Truist Financial increased their price target on shares of Laboratory Co. of America from $255.00 to $275.00 and gave the company a “buy” rating in a report on Friday, August 2nd. Five analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $255.92.

Institutional Trading of Laboratory Co. of America

Several large investors have recently bought and sold shares of LH. SouthState Corp bought a new position in shares of Laboratory Co. of America in the third quarter worth about $28,000. Horizon Bancorp Inc. IN bought a new position in Laboratory Co. of America in the 3rd quarter valued at approximately $29,000. Pathway Financial Advisers LLC bought a new position in Laboratory Co. of America in the 1st quarter valued at approximately $30,000. Industrial Alliance Investment Management Inc. acquired a new stake in Laboratory Co. of America in the second quarter valued at approximately $27,000. Finally, Innealta Capital LLC bought a new stake in shares of Laboratory Co. of America during the second quarter worth $32,000. 95.94% of the stock is owned by institutional investors and hedge funds.

Laboratory Co. of America Company Profile

Labcorp Holdings Inc provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.